NCT07607444

Brief Summary

The goal of this clinical trial is to learn if Cognitive Behavioral Therapy for Insomnia (CBT-I) can treat insomnia complaints in participants physically active; men and woman; aged 30-59 years old. The main question it aims to answer is: Can this terapy to reduce the insomnia severity? Can this terapy to improve sleep and related complaints? Researchers will compare CBT-I vs No treatment to see if CBT-I can promote better sleep. Participants will receive 6 weeks of treatment.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
43mo left

Started Jul 2026

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 26, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2026

Expected
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2029

Last Updated

May 28, 2026

Status Verified

May 1, 2026

Enrollment Period

6 months

First QC Date

May 19, 2026

Last Update Submit

May 26, 2026

Conditions

Keywords

insomniacognitive behavioral therapyphysical activity

Outcome Measures

Primary Outcomes (1)

  • Insomnia severity

    The Insomnia Severity Index is a questionnaire that assesses insomnia complaints. It is a self-administered, simple and short instrument, with seven items that can be classified from 0 to 4, with the lowest final score = 0 and the highest = 28. Non-significant insomnia is considered scores from 0 to 7, lower limit for insomnia from 8 to 14, moderate insomnia from 15 to 21 and severe insomnia from 22 to 28.

    (1) at baseline (pre-intervention), (2) six weeks, and (3) four weeks of follow-up.

Secondary Outcomes (6)

  • Sleep assessment by Actigraphy

    (1) at baseline (pre-intervention), (2) six weeks and (3) four weeks of follow-up

  • Sleep quality

    (1) at baseline (pre-intervention), (2) six weeks, and (3) four weeks of follow-up.

  • Pré-sleep arousal

    (1) at baseline (pre-intervention), (2) six weeks, and (3) four weeks of follow-up.

  • Subjective sleep

    (1) at baseline (pre-intervention), (2) six weeks, and (3) four weeks of follow-up.

  • Emotional Distress

    (1) at baseline (pre-intervention), (2) six weeks, and (3) four weeks of follow-up.

  • +1 more secondary outcomes

Other Outcomes (5)

  • Body mass

    Baseline (pre-intervention)

  • Chronotype

    Baseline (pre-intervention)

  • Physical activity level

    baseline (pre-intervention)

  • +2 more other outcomes

Study Arms (2)

Treatment group (CBT-I)

EXPERIMENTAL

This group will receive 6 weeks of CBT-I treatment

Behavioral: Cognitive behavioral treatment for insomnia

Control group

NO INTERVENTION

This group will receive no treatment

Interventions

This intervention is a multicomponent therapy directed to insomnia treatment. It includes sleep restriction, cognitive therapy, stimulus control, sleep higiene, and relaxation therapy (Van Straten et la., 2018)

Treatment group (CBT-I)

Eligibility Criteria

Age30 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age range between 30-59 years;
  • Practice regular physical exercise for over 150 minutes per week;
  • Complaints of insomnia (difficulty initiating and/or maintaining sleep and/or early awakening) more than three times a week, for at least three months, associated with complaints of daytime impairments (occupational, academic or social) related to insomnia;
  • Insomnia severity index greater than fifteen (\>15).

You may not qualify if:

  • Shift workers;
  • Evidence that insomnia is associated with restless legs syndrome;
  • Evidence that insomnia is associated with medication side effects;
  • Evidence that insomnia is associated with signs or symptoms of mental disorders;
  • Abusive use of alcohol or illicit psychoactive substances.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (10)

  • van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Med Rev. 2018 Apr;38:3-16. doi: 10.1016/j.smrv.2017.02.001. Epub 2017 Feb 9.

    PMID: 28392168BACKGROUND
  • Reis R, Teixeira F, Martins V, Sousa L, Batata L, Santos C, Moutinho J. Validation of a Portuguese version of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnea: Analysis in a sleep clinic. Rev Port Pneumol (2006). 2015 Mar-Apr;21(2):61-8. doi: 10.1016/j.rppnen.2014.04.009. Epub 2015 Feb 7.

    PMID: 25926368BACKGROUND
  • Masuko AH, Carvalho LB, Machado MA, Morais JF, Prado LB, Prado GF. Translation and validation into the Brazilian Portuguese of the restless legs syndrome rating scale of the International Restless Legs Syndrome Study Group. Arq Neuropsiquiatr. 2008 Dec;66(4):832-6. doi: 10.1590/s0004-282x2008000600011.

    PMID: 19099121BACKGROUND
  • Vignola RC, Tucci AM. Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese. J Affect Disord. 2014 Feb;155:104-9. doi: 10.1016/j.jad.2013.10.031. Epub 2013 Oct 28.

    PMID: 24238871BACKGROUND
  • Ruivo Marques D, Allen Gomes A, Nicassio PM, Azevedo MHP. Pre-Sleep Arousal Scale (PSAS): psychometric study of a European Portuguese version. Sleep Med. 2018 Mar;43:60-65. doi: 10.1016/j.sleep.2017.10.014. Epub 2017 Dec 19.

    PMID: 29482814BACKGROUND
  • Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989 May;28(2):193-213. doi: 10.1016/0165-1781(89)90047-4.

    PMID: 2748771BACKGROUND
  • Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic review. Int J Behav Nutr Phys Act. 2011 Oct 21;8:115. doi: 10.1186/1479-5868-8-115.

    PMID: 22018588BACKGROUND
  • Horne JA, Ostberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4(2):97-110.

    PMID: 1027738BACKGROUND
  • Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. doi: 10.1016/s1389-9457(00)00065-4.

    PMID: 11438246BACKGROUND
  • Sadeh A, Hauri PJ, Kripke DF, Lavie P. The role of actigraphy in the evaluation of sleep disorders. Sleep. 1995 May;18(4):288-302. doi: 10.1093/sleep/18.4.288.

    PMID: 7618029BACKGROUND

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersMotor Activity

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersBehavior

Study Officials

  • Giselle S Passos, PhD

    Federal University of Jatai

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Giselle Soares Passos, PhD

CONTACT

Tamara R.L. Zanuzzi, Master´s

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
the statistician
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 19, 2026

First Posted

May 26, 2026

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 30, 2029

Last Updated

May 28, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

The ethics committee guarantees the privacy of all participants.